I
EW icon

IberiaBank’s Edwards Lifesciences EW Stock Holding History

IberiaBank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$6.76M Sell
97,827
-10,200
-9% -$725K 0.8% 42
2020
Q1 		$6.79M Buy
108,027
+336
+0.3% +$24.2K 0.89% 36
2019
Q4 		$8.37M Buy
107,691
+2,058
+2% +$161K 0.88% 39
2019
Q3 		$7.74M Sell
105,633
-12,150
-10% -$853K 0.89% 41
2019
Q2 		$7.25M Buy
117,783
+11,082
+10% +$670K 0.8% 47
2019
Q1 		$6.8M Buy
106,701
+10,569
+11% +$603K 0.79% 45
2018
Q4 		$4.91M Buy
96,132
+24,108
+33% +$1.22M 0.64% 52
2018
Q3 		$4.18M Buy
72,024
+18,999
+36% +$929K 0.52% 62
2018
Q2 		$2.57M Buy
53,025
+4,515
+9% +$211K 0.45% 75
2018
Q1 		$2.26M Buy
48,510
+1,404
+3% +$61K 0.45% 80
2017
Q4 		$1.77M Buy
47,106
+3,273
+7% +$120K 0.28% 108
2017
Q3 		$1.6M Buy
43,833
+4,242
+11% +$162K 0.27% 111
2017
Q2 		$1.56M Buy
39,591
+3,600
+10% +$131K 0.46% 76
2017
Q1 		$1.13M Buy
35,991
+23,913
+198% +$749K 0.36% 92
2016
Q4 		$377K Buy
12,078
+5,889
+95% +$191K 0.14% 116
2016
Q3 		$249K Sell
6,189
-10,875
-64% -$410K 0.11% 120
2016
Q2 		$567K Buy
17,064
+102
+0.6% +$3.49K 0.25% 79
2016
Q1 		$499K Buy
16,962
+402
+2% +$11.1K 0.24% 80
2015
Q4 		$436K Buy
16,560
+1,602
+11% +$41.6K 0.2% 98
2015
Q3 		$354K Buy
14,958
+4,134
+38% +$99.8K 0.18% 102
2015
Q2 		$257K Buy
10,824
+894
+9% +$20.2K 0.11% 146
2015
Q1 		$236K Buy
+9,930
New +$223K 0.11% 165

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

IberiaBank's EW Position: Q2 2020 in Review

IberiaBank reduced its Edwards Lifesciences (EW) stake by 9.4% in Q2 2020, selling an estimated $725K and leaving 97,827 shares worth $6.76M. The position accounts for 0.8% of the portfolio, ranked #42.

IberiaBank first reported a position in EW in Q1 2015 and has held it in 22 quarters since. The position peaked at $8.37M in Q4 2019. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • IberiaBank held 97,827 shares of Edwards Lifesciences worth $6.76M as of Q2 2020.
  • IberiaBank sold 10,200 Edwards Lifesciences shares in Q2 2020, an estimated $725K.
  • Edwards Lifesciences made up 0.8% of IberiaBank's portfolio in Q2 2020, its #42 holding.
  • IberiaBank first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 22 quarters since.
  • IberiaBank's Edwards Lifesciences position peaked at $8.37M in Q4 2019.
  • 1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on IberiaBank's 13F filing for Q2 2020, filed 29 Jul 2020.